Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ralf Beyrau"'
Autor:
Barbara Handschin, Mira Katan, Regula Schüpbach, Ralf Beyrau, Martin Voss, Katrin Conen, Katharina Rentsch, Diana Zwahlen, Günter Eisele, Deborah R. Vogt, Viviane Hess, Michael Weller, Joachim P. Steinbach
Publikováno v:
Journal of Clinical Oncology. 35:e13524-e13524
e13524 Background: Diagnosis and treatment of glioblastoma (GBM), the most common and aggressive malignant brain tumor in adults, impose profound chronic distress on patients and their partners. In order to assess how distress in patients and partner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dd050a550afe30f85ae1e86b1edab08
https://doi.org/10.1200/jco.2017.35.15_suppl.e13524
https://doi.org/10.1200/jco.2017.35.15_suppl.e13524
Autor:
Hans-Peter Heinz, Jan Verhoef, Franz-Josef Schmitz, Ad C. Fluit, Elke Lindenlauf, Ralf Beyrau, Mark E. Jones, Mechthild Gondolf
Publikováno v:
Journal of Antimicrobial Chemotherapy. 43:253-259
Aminoglycosides still play an important role in antistaphylococcal therapies, although emerging resistance amongst staphylococci is widespread. To further our understanding of the prevalence of aminoglycoside resistance in Europe, we tested 699 and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44ce0db1300f47e60c06349e1e624d5f
https://doi.org/10.1093/jac/43.2.253
https://doi.org/10.1093/jac/43.2.253
Publikováno v:
Forum Médical Suisse ‒ Swiss Medical Forum. 12
In den letzten Monaten haben mehrere internationale Diabetes-Fachgesellschaften neu das HbA1c als zusatzliches, aquivalentes Diagnosekriterium eingefuhrt. Man beachte die Storgrossen, die zu einer Veranderung des HbA1C-Wertes fuhren konnen...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7103ea33123b34592578bbd4b50ae0ef
https://doi.org/10.4414/fms.2012.01137
https://doi.org/10.4414/fms.2012.01137
Autor:
Michael Bodmer, Stephan Krähenbühl, Oliver Kummer, Ralf Beyrau, Manuel Haschke, Thilo Burkard
Publikováno v:
Therapeutic drug monitoring. 30(4)
We present a case of massive overdose with the atypical antipsychotic quetiapine in a 34-year-old woman (body weight 65 kg). At admission, approximately 2 to 4 hours after ingestion of approximately 24 g of quetiapine, the patient was comatose (Glasg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752c422ccd9e534fbbc2d0baa3e252cc
https://pubmed.ncbi.nlm.nih.gov/18641548
https://pubmed.ncbi.nlm.nih.gov/18641548
Autor:
Petra, Stieber, Rafael, Molina, Daniel W, Chan, Herbert A, Fritsche, Ralf, Beyrau, Jean M G, Bonfrer, Xavier, Filella, Terrie G, Gornet, Torsten, Hoff, Wolfram, Jäger, Gerard J, van Kamp, Dorothea, Nagel, Klaus, Peisker, Lori J, Sokoll, Frédéric, Troalen, Michael, Untch, Ingrid, Domke
Publikováno v:
Clinical laboratory. 49(1-2)
The aim of the present study was to evaluate the clinical performance of the CA 15-3 assay on Elecsys systems in an international multicenter study (11 centers). A total of 1326 single samples (272 apparently healthy individuals, 34 pregnant women, 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::319febe83cb7729ab80c3e51af2f7471
https://pubmed.ncbi.nlm.nih.gov/12593471
https://pubmed.ncbi.nlm.nih.gov/12593471
Autor:
Wolfram Jäger, Klaus Peisker, Gerard J. van Kamp, Jean M.G. Bonfrer, Terrie G. Gornet, Daniel W. Chan, Herbert A. Fritsche, Dorothea Nagel, Ingrid Domke, Torsten Hoff, Petra Stieber, Frédéric Troalen, Lori J. Sokoll, Xavier Filella, Ralf Beyrau, Michael Untch, Rafael Molina
Publikováno v:
Clinical chemistry. 47(12)
Although the sensitivity and specificity of CA 15-3 in primary diagnosis of breast cancer is limited, CA 15-3 measurement has found widespread use in monitoring disease progression and response to therapy [reviewed in Ref. (1)]. A new assay for deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c012b22dea6d860074bf02694d72ef25
https://pubmed.ncbi.nlm.nih.gov/11719486
https://pubmed.ncbi.nlm.nih.gov/11719486
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 227(1-2)
The determination of the angiotensin I-converting enzyme activity (ACE, kininase II, peptidyldipeptide hydrolase, EC 3.4.15.1) is necessary to control the course and the treatment of sarcoidosis, as well as to monitor the therapeutic use of enzyme in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7747e4cd715dd2d2748694a369c421
https://pubmed.ncbi.nlm.nih.gov/7955411
https://pubmed.ncbi.nlm.nih.gov/7955411